Results 261 to 270 of about 417,636 (395)

Logit-Transformation [PDF]

, 2019
openaire   +1 more source

Gender in old care: comparing sons' and daughters' role in parental functional and psychological well-being. [PDF]

BMC Geriatr
Du X, Wei H, Zhang X, Bai C.
europepmc   +1 more source

Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Percutaneous coronary intervention (PCI) after transcatheter aortic valve replacement (TAVR) has gained interest as concomitant coronary artery disease (CAD) is now often treated conservatively before TAVR, and TAVR is increasingly used in younger patients with longer life expectancies. Therefore, more contemporary data on PCI after
Hugo M. Aarts, Kimberley I. Hemelrijk, Gijs M. Broeze, Steven A. Muller, Lineke Derks, Ronak Delewi, Michiel Voskuil, the Transcatheter Heart Intervention and Percutaneous Coronary Intervention registration committees of the Netherlands Heart Registration   +7 more
wiley   +1 more source

The Recovering Quality of Life - Utility Index (ReQoL-UI): the Hong Kong valuation study. [PDF]

Health Qual Life Outcomes
Xu RH, Yang C, Thai T, Wong EL, Ng SSM, Norman R.   +5 more
europepmc   +1 more source

Rank‐based estimation of propensity score weights via subclassification

Canadian Journal of Statistics, EarlyView.
Abstract Propensity score (PS) weighting estimators are widely used for causal effect estimation and enjoy desirable theoretical properties, such as consistency and potential efficiency under correct model specification. However, their performance can degrade in practice due to sensitivity to PS model misspecification.
Linbo Wang, Yuexia Zhang, Thomas S. Richardson, Xiaohua Zhou   +3 more
wiley   +1 more source

Deriving Drug Treatment Preference for Osteoporosis Patients Using Discrete Choice Experiments: A Scoping Review. [PDF]

Patient Prefer Adherence
Wang Y, Lu H, Liu G, Niu C, Zhang Z, Zhan Q, Liu M, Qin H.   +7 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source

Constrained Assortment and Price Optimization under Generalized Nested Logit Models [PDF]

Hoang Giang Pham, Tien Mai
openalex  

Improving Transferable Targeted Adversarial Attack via Normalized Logit Calibration and Truncated Feature Mixing [PDF]

Juanjuan Weng, Zhiming Luo, Shaozi Li
openalex   +1 more source

Cooking fuel choices and household respiratory health in Nigeria. [PDF]

BMC Public Health
Olasehinde N, Ajayi P, Oloyede O.
europepmc   +1 more source